INTRODUCTION {#s1}
============

The Sonic hedgehog (Shh) signaling pathway regulates diverse cellular processes ([@BIO040592C21]). In the nervous system, besides its best-characterized role in patterning the embryonic neural tube ([@BIO040592C8]; [@BIO040592C11]), there is accumulating evidence that Shh signaling continues to exist post-embryonically and carries out a range of functions. For example, Shh is known as a mitogen for different populations of neural precursors or progenitor cells ([@BIO040592C43]; [@BIO040592C24]; [@BIO040592C30]; [@BIO040592C20]). Shh also controls specific properties of astrocytes in the brain ([@BIO040592C15]; [@BIO040592C14]). Furthermore, Shh has been found to be important for the growth of axons in several types of neurons including spinal cord commissural neurons ([@BIO040592C5]; [@BIO040592C29]), midbrain dopaminergic neurons ([@BIO040592C19]), and hippocampal neurons ([@BIO040592C45]). In the case of hippocampal neurons, Shh-stimulated axonal growth is accompanied by elevated Gli1 expression ([@BIO040592C45]), enhanced autophagy ([@BIO040592C36]), and activated mitochondria ([@BIO040592C46]). Despite the abiding interest in what roles Shh plays in the nervous system, limited attention has been given to the source and biogenesis of Shh itself, particularly the endogenous Shh levels in the natural non-genetically modified brain. In this study, we have systematically examined Shh levels in the brain at different ages from embryos to young adults and have established a temporal expression of Shh. Our analysis reveals appreciable amounts of Shh in postnatal and young adult brains, including in the hippocampus.

RESULTS {#s2}
=======

Endogenous Shh expression levels in the rat brain during embryonic and postnatal development {#s2a}
--------------------------------------------------------------------------------------------

Starting with Shh mRNA, we measured its expression levels in the rat cortex from embryonic day 14 (e14) to postnatal day 30 (p30) using quantitative RT-PCR. Analysis of four biological replicates (number of embryos or pups) revealed that Shh mRNA level in the cortex was high at e14, but declined gradually as embryos developed, and became undetectable at birth (top graph in [Fig. 1](#BIO040592F1){ref-type="fig"}A). Notably, after birth and throughout postnatal development, Shh mRNA became detectable again and its level increased steadily as young rats matured, and reached a plateau between p21 and p30 (p21 versus p1, 7.6±2.1 versus 1, *P*=0.0259; p30 versus p1, 7.0±1.4 versus 1, *P*=0.0084; top graph in [Fig. 1](#BIO040592F1){ref-type="fig"}A). Data from RT-PCR analysis using a different PCR primer set (Materials and Methods) showed the same two-peaked pattern ([Fig. S1](Fig. S1)A). Fig. 1.**Shh mRNA and ShhN protein expression levels in rat brains during embryonic and postnatal development.** (A) Quantitative RT-PCR assay of Shh mRNA level in rat cortex from embryonic day 14 (e14) to postnatal day 30 (p30). For comparison, mRNA levels of Bdnf and synaptic markers, bassoon and synaptophysin, were also assayed. The data were expressed as fold change from p1 and plotted against age (*n*=the number of rat embryos or pups per age). For e14 embryos, whole brains were used. Data of quantitative RT-PCR using a different Shh primer set are shown in [Fig. S1](Fig. S1)A. (B) Shh mRNA level in postnatal rat hippocampus and cerebellum from p1 to p30. (C) Immunoblot with an antibody to N-terminal epitope of Shh. Lanes contain lysates from HEK cells transfected with wild-type full-length Shh (ShhFL), N-terminal fragment of Shh (ShhN), or vector. The ShhN antibody detects N-terminal fragment (∼19 kD) and full-length (∼45 kD) Shh. (D) Immunoblot with the ShhN antibody showing the ∼19 kD ShhN as the main Shh species in tissue extracts from e14 or e16 rat brains. A similar finding from mouse brain extracts using this antibody is shown in [Fig. S1](Fig. S1)B. Also, a similar finding from rat brain extracts but using a different ShhN antibody is shown in [Fig. S1](Fig. S1)C. (E) Immunoblot analysis of ShhN protein level in rat cortex from embryonic day 14 (e14) to postnatal day 30 (p30). ShhN level is high during embryonic development, declines to a nearly undetectable level at birth, and increases again during late postnatal development. Blot shown is one representative experiment; blots of additional experiments are shown in [Fig. S1](Fig. S1)D. Histogram includes at least three experiments. (F,G) Immunoblot analysis showing that, similar to cortex, ShhN protein level in hippocampus (F) and cerebellum (G) increases during late postnatal development. Syp, synaptophysin. Error bars represent s.e.m. \*\*\**P*\<0.001, \*\**P*\<0.01, \**P*\<0.05, unpaired *t*-test. The values of ShhN protein level represent the ShhN band intensities normalized to the actin band intensities.

For comparison, we measured mRNA levels of brain-derived neurotrophic factor (Bdnf) in the same set of cortical samples. Unlike Shh mRNA expression, Bdnf mRNA was undetectable before birth at all embryonic ages examined (middle graph in [Fig. 1](#BIO040592F1){ref-type="fig"}A). But similar to Shh mRNA expression, Bdnf mRNA level increased continuously during postnatal development and reached a peak level between p21 and p30 (middle graph in [Fig. 1](#BIO040592F1){ref-type="fig"}A). Knowing that synapses develop rapidly during postnatal development ([@BIO040592C32]; [@BIO040592C37]), we measured mRNAs of two well-characterized synaptic proteins, bassoon and synaptophysin ([@BIO040592C18]; [@BIO040592C23]). As expected, bassoon and synaptophysin mRNA increased markedly from birth to p21 or p30 (bottom graph in [Fig. 1](#BIO040592F1){ref-type="fig"}A). Although relative Shh mRNA abundance in the postnatal cortex was lower compared with mRNA for Bdnf and synaptic markers, the temporal expression pattern of Shh mRNA was nearly identical to that of Bdnf and synaptic markers.

We examined two additional brain regions, the hippocampus and cerebellum, concentrating on postnatal ages. Similar to the cortex, Shh mRNA levels in both hippocampus and cerebellum increased steadily during postnatal development ([Fig. 1](#BIO040592F1){ref-type="fig"}B). At p30, the level of Shh mRNA was significantly higher than the level at birth (p30 versus p1 hippocampus, 4.2±0.7 versus 1, *P*=0.0465; p30 versus p1 cerebellum, 3.9±0.2 versus 1, *P*=0.0069; [Fig. 1](#BIO040592F1){ref-type="fig"}B).

We subsequently examined Shh protein level in the embryonic and postnatal cortex. We used a commercially available antibody to the N-terminal epitope of Shh (see Materials and Methods). We refer to this antibody as the ShhN antibody. We first evaluated the ShhN antibody by immunoblotting cell lysates from human embryonic kidney (HEK) cells that were transfected with the expression construct either for wild-type full-length Shh protein (ShhFL), or N-terminal fragment of Shh protein (ShhN) (Materials and Methods). As revealed in the blot shown in [Fig. 1](#BIO040592F1){ref-type="fig"}C, the antibody specifically recognized the expected ∼45 kD ShhFL and ∼19 kD ShhN ([@BIO040592C25]). The lack of any Shh protein band from the vector-transfected cells validated the specificity of the ShhN antibody, as HEK cells do not produce endogenous Shh ([@BIO040592C6],[@BIO040592C7]). In brain tissue extracts, the antibody detected the ∼19 kD ShhN, not the ∼45 kD ShhFL ([Fig. 1](#BIO040592F1){ref-type="fig"}D; with a similar finding in mouse brain extracts, see [Fig. S1](Fig. S1)B). A different ShhN antibody (5E1; [@BIO040592C13]; [@BIO040592C35]) ([Fig. S1](Fig. S1)C) similarly showed that the predominant form of Shh protein in brains is the ∼19 kD ShhN. Therefore, we focused on examining this Shh form in brains at different ages.

The temporal expression pattern of ShhN protein mirrored the pattern of Shh mRNA in the cortex: both were highly expressed at e14, gradually declined to a nearly undetectable level at birth, and steadily increased during postnatal development ([Fig. 1](#BIO040592F1){ref-type="fig"}E; [Fig. S1](Fig. S1)D). Moreover, in postnatal hippocampus and cerebellum, again the protein was low in p1, but by p30, ShhN protein level was significantly higher than in p1 (p30 versus p1 hippocampus, 61±11.7 versus 7±3, *P*=0.037; p30 versus p1 cerebellum, 105.5±17.9 versus 17.5±6.9, *P*=0.0108; [Fig. 1](#BIO040592F1){ref-type="fig"}F,G). Together, these observations supported significant expression of Shh mRNA and ShhN protein in postnatal and young adult rat brain including the cortex, hippocampus and cerebellum. The closely correlated temporal expression pattern between mRNA and protein suggested that transcription regulation contributed at least in part to the level of Shh protein.

ShhN protein level in hippocampal neurons {#s2b}
-----------------------------------------

Having found progressively increased expression of endogenous ShhN in the hippocampus during postnatal development, we examined the abundance of this protein in hippocampal neuronal cultures, a model system in which developmental stages of neurons are well described ([@BIO040592C12]; [@BIO040592C17]). Immunoblots using the ShhN antibody showed that ShhN was also the most prominent Shh protein in neuronal lysates ([Fig. 2](#BIO040592F2){ref-type="fig"}A; [Fig. S2](Fig. S2)A), similar to what we observed in brain extracts ([Fig. 1](#BIO040592F1){ref-type="fig"}; [Fig. S1](Fig. S1)). Therefore, we focused on examining ShhN in these neurons. Comparing with the same amount of total protein (30 µg) from the lysates, ShhN was undetectable in very young neurons (1 or 2 days in culture), low but detectable as neurons grew (7 days in culture), and easily detectable in mature neurons (14 to 21 days in culture) (21 days versus 1 day, 103±11 versus 17.3±4.4; *P*=0.0022; [Fig. 2](#BIO040592F2){ref-type="fig"}A,B; [Fig. S2](Fig. S2)B). Fig. 2.**ShhN protein expression levels in cultured hippocampal neurons.** (A) Immunoblot showing increased ShhN protein level in hippocampal neurons as these neurons matured in culture. d, days in culture. Proteins from HEK cells expressing N-terminal fragment of Shh (ShhN) or full-length Shh (ShhFL) assayed in the same blot as controls. The ShhN antibody detects N-terminal fragment Shh (∼19 kD) as well as full-length Shh (∼45 kD) from HEK cell lysates, whereas in lysates of cultured neurons, ShhN is the dominant Shh species. psd95, a synaptic marker. Additional blots are shown in [Fig. S2](Fig. S2)A,B. (B) Quantification of A. *n*=number of independent cultures. (C) Immunoblot showing similar ShhN protein level in neuron-enriched cultures (Enriched) and standard cultures (Standard). Gfap and Aldh1L1 are glial markers, Syp, synaptophysin, neuronal synaptic marker. (D) Quantification of C. *n*=number of independent cultures. (E,F) Neural activity does not change overall ShhN level. PACAP (10 nM), 2 h; Bicuculline (40 µM), 12 h; ttx, tetrodotoxin (2 µM). (G,H) While treatment of cultured neurons with Shh pathway agonist Purmorphamine (3.6 µM) robustly increases Gli1mRNA level (top, bar graph), the overall level of ShhN protein is not changed (bottom, representative blot) and H. Error bars represent s.e.m. \*\**P*\<0.01, unpaired *t*-test. The values of ShhN protein level represent the ShhN band intensities normalized to the actin band intensities.

We wondered whether there were any detectable amounts of extracellular Shh in these hippocampal neurons as they matured in culture. We collected the media from the neurons at various ages and measured ShhN by immunoblots. In spite of concentrating the media (first 25-fold and then tenfold), immunoblots did not show Shh from neurons of any culture ages ([Fig. S2](Fig. S2)C).

Because standard hippocampal neuron cultures comprise not only neurons but also glia, such as astrocytes, we sought to measure ShhN levels in neuron-enriched cultures by treating the standard cultures with AraC (Materials and Methods). Although treatment of AraC eliminated most astrocytes as demonstrated by the disappearance of Gfap and Aldh1L1, markers for astrocytes ([@BIO040592C3]), ShhN levels were similar between neuron-enriched cultures and the standard cultures ([Fig. 2](#BIO040592F2){ref-type="fig"}C,D). These results confirmed that neurons produced Shh. Therefore, we used the standard cultures in the remaining experiments of this study.

Given that neural activity upregulates Bdnf mRNA expression ([@BIO040592C31]; [@BIO040592C16]; [@BIO040592C44]), we next investigated whether enhanced neural activity alters basal ShhN level in hippocampal neurons. We stimulated the neurons by treating them with bicuculline (a GABA~A~ receptor antagonist) or PACAP (the neuropeptide pituitary adenylate cyclase activating polypeptide) ([@BIO040592C1]; [@BIO040592C44]). Although cFos level, a sensitive readout for neuronal activity, was markedly increased in the treated neurons, the ShhN level remained unchanged ([Fig. 2](#BIO040592F2){ref-type="fig"}E,F). Thus, our data suggested that the endogenous global level of ShhN in neurons was not regulated by neural activity.

Finally, we asked if the activity of the Shh pathway itself affected ShhN level in hippocampal neurons. We treated the neurons with Purmorphamine, a Shh agonist ([@BIO040592C38]). In the parallel samples, we measured Gli1 mRNA, a sensitive and reliable readout of the Shh pathway activity ([@BIO040592C21]; [@BIO040592C42]). RT-PCR analysis showed a time-dependent increase in Gli1 mRNA upon Purmorphamine treatment with an ∼eightfold higher level than untreated control after 24 h (top graph in [Fig. 2](#BIO040592F2){ref-type="fig"}G). Despite robustly enhanced Shh pathway activity, Purmorphamine treatment did not change the basal ShhN level in these neurons ([Fig. 2](#BIO040592F2){ref-type="fig"}G,H).

Shh protein spatial distribution in hippocampal neurons {#s2c}
-------------------------------------------------------

In *Drosophila* photoreceptor neurons, different fragments of Hedgehog (Hh) protein are segregated in different parts of the cells ([@BIO040592C9]; [@BIO040592C10]). We wanted to know if in mammalian neurons, various Shh protein fragments or forms preferentially localize to particular neuronal compartments. For this analysis, we examined the well-defined subcellular compartments in the cultured hippocampal neuron ([@BIO040592C12]; [@BIO040592C17]).

In addition to the ShhN antibody which we have characterized ([Figs 1](#BIO040592F1){ref-type="fig"}C,D, [2](#BIO040592F2){ref-type="fig"}A; [Fig](Fig)s[ S1]( S1)B, [2](2)A), we tested an antibody to a C-terminal epitope of Shh which we refer to as ShhC antibody (see Materials and Methods). Immmunoblots of cell lysates from HEK cells transfected with ShhFL showed that the ShhC antibody detected ShhFL (∼45 kD), and a protein band at ∼25 kD ([Fig. 3](#BIO040592F3){ref-type="fig"}A; [Fig. S3](Fig. S3)A), the expected size for ShhC protein fragment ([@BIO040592C25]). In contrast, and as expected, the ShhC antibody did not detect the ∼19 kD ShhN from HEK cells that were transfected with ShhN ([Fig. 3](#BIO040592F3){ref-type="fig"}A; [Fig. S3](Fig. S3)A), supporting the specificity of the ShhC antibody in detecting ShhC in addition to ShhFL. Fig. 3.**ShhN and ShhC/FL distribution in cultured hippocampal neurons.** (A) Immunoblot with an antibody to C-terminal epitope of Shh (amino acids 199-437 of mouse Shh). Lanes contain lysates from hippocampal neurons (21 days in culture; 10--40 µg total proteins), and from HEK cells expressing the N-terminal fragment of Shh (ShhN) or full-length Shh (ShhFL). Whereas the ShhC antibody does not detect the N-terminal Shh fragment (∼19 kD) as expected, the antibody detects the full-length Shh (∼45 kD) and C-terminal Shh fragment (∼25 kD) from both ectopically expressed and endogenous Shh. Additional blot of ectopically expressed Shh is shown in [Fig. S3](Fig. S3)A. (B) Fluorescent images of hippocampal neurons co-labeled for ShhN (green) or ShhC/FL (green), an axonal marker smi312 (yellow) and a dendritic marker map2 (magenta). (C) Representative image of a hippocampal neuron showing a trend of higher ShhN (red) immunofluorescence intensity in soma (cell body) but a relatively even ShhC/FL (green) distribution throughout neurites. Additional examples are shown in [Fig. S3](Fig. S3)B. (D) Comparing neurite to soma ratio of ShhN and ShhC/FL fluorescence intensity. *n*=30 cells from three cultures. (E,F) Representative image of a hippocampal neuron with an enlarged area (F) showing examples of ShhN-alone immunolabeled puncta (arrow labeled N), ShhC/FL-alone puncta (arrows labeled C), or ShhN and ShhC/FL puncta next to each other (arrows labeled N/C). (G) Quantification of E and F. *n*=30 cells from three cultures. Scale bars: 10 µm.

In neuronal lysates, immunoblot with the ShhC antibody revealed that ShhC (∼25 kD) co-migrated with the ShhC from the expressed construct ([Fig. 3](#BIO040592F3){ref-type="fig"}A). Notably, in immunoblots of both neurons and transfected HEK cells, ShhC levels were lower than the levels of ShhFL and appeared as double bands in some cases. The unambiguous detection of ShhN by the ShhN antibody ([Fig. 2](#BIO040592F2){ref-type="fig"}A) and ShhC by the ShhC antibody ([Fig. 3](#BIO040592F3){ref-type="fig"}A) indicate that both of these Shh forms are produced in neurons, as shown for other types of cells ([@BIO040592C4]; [@BIO040592C25]). Although the ShhN and ShhC must be derived from ShhFL ([@BIO040592C25]), no definitive answer about the abundance or presence of neuronal ShhFL can be deduced from our immunoblots because this FL form was detected with the ShhC antibody ([Fig. 3](#BIO040592F3){ref-type="fig"}A) but not with the ShhN antibody ([Fig. 2](#BIO040592F2){ref-type="fig"}A).

We next visualized and compared spatial distributions of ShhN and ShhC in hippocampal neurons. Using immunolabeling analysis, we first examined hippocampal neurons that had grown in culture for 2--3 days because neurons at this stage have developed distinctive axons and dendrites ([@BIO040592C12]; [@BIO040592C17]). We co-immunolabeled the neurons with the antibody for ShhN or ShhC, and with antibodies to an axonal marker smi312 and dendritic marker map2 ([Fig. 3](#BIO040592F3){ref-type="fig"}B). Because immunoblots of neuronal lysates showed the ShhC antibody detecting both ShhC and ShhFL ([Fig. 3](#BIO040592F3){ref-type="fig"}A), ShhC immunolabeling signals could be indicative of ShhC or ShhFL or both; therefore, we designated ShhC-immunolabeled signals as ShhC/FL.

Overall, neither ShhN nor ShhC/FL immunolabeling displayed any noticeable spatial distribution differences between axons, dendrites or soma. Upon closer inspection, however, we noticed that ShhN immunolabeling tended to be higher in soma and proximal regions of axons and dendrites, whereas ShhC/FL immunolabeling was more uniform and widespread throughout the entire neurons ([Fig. 3](#BIO040592F3){ref-type="fig"}B).

When we co-labeled for ShhN and ShhC/FL in slightly older neurons (7 days in culture), the difference in the overall distribution pattern between the two Shh forms became more apparent: ShhN appeared higher in the soma than in neurites, whereas ShhC/FL labeling intensity was uniform between the soma and neurites in some cells or higher in neurites than in the soma in other cells ([Fig. 3](#BIO040592F3){ref-type="fig"}C; [Fig. S3](Fig. S3)B). Quantitative assessment of immunofluorescence intensity expressed as neurite to soma ratio confirmed our visual impression: ShhN was higher in soma than neurites whereas ShhC/FL on average was higher in neurites than soma ([Fig. 3](#BIO040592F3){ref-type="fig"}D).

Further examination of individual ShhN or ShhC/FL immunolabeled dots or puncta revealed three populations: ShhN alone, ShhC alone, and ShhN and ShhC/FL co-localized or closely opposed to each other ([Fig. 3](#BIO040592F3){ref-type="fig"}E,F). Counting the puncta number in the proximal area of neurites (i.e. white box in [Fig. 3](#BIO040592F3){ref-type="fig"}E) showed ∼20% ShhN puncta, ∼45% ShhC/FL puncta, and ∼35% ShhN and ShhC/FL co-labeled puncta ([Fig. 3](#BIO040592F3){ref-type="fig"}G). The overlapping ShhN and ShhC/FL fluorescent signals imply a physical association between the different Shh forms. The dually labeled puncta may represent various combinations of ShhFL, ShhN and ShhC.

Shh protein distribution in synapses of hippocampal neurons {#s2d}
-----------------------------------------------------------

Based on the observation that ShhN and ShhC were detected in synaptosomal preparations of rat brains ([Fig. 4](#BIO040592F4){ref-type="fig"}A; ShhFL is not shown), we visualized the distribution of ShhN and ShhC/FL in synapses of mature hippocampal neurons (at least 21 days in culture). We co-immunolabeled ShhN or ShhC/FL with a presynaptic marker, bassoon and a postsynaptic marker, homer ([Fig. 4](#BIO040592F4){ref-type="fig"}B; [Fig. S4](Fig. S4)A). Using confocal microscopy with Airyscan (Zeiss 880, with ∼140 nm xy and 400 nm z resolution), we observed that ShhN and ShhC/FL immunolabeling were similarly juxtaposed to bassoon and homer ([Fig. 4](#BIO040592F4){ref-type="fig"}B; [Fig. S4](Fig. S4)A). Although our observations indicate that both forms of Shh are closely associated with synapses, it is important to note that confocal microscopy even with Airyscan does not offer sufficient resolution to definitively resolve the compartments of single synapses. Fig. 4.**ShhN and ShhC localization in synapses of hippocampal neurons.** (A) Immunoblots of synaptic preparations from rat brains showing the presence of ShhN and ShhC in synapses. psd95, a synaptic marker. Blots of two different exposures are shown. (B,C) Fluorescent images of mature hippocampal neuron (21 days in culture) co-labeled for ShhN (green in B) or ShhC/FL (green in C), a presynaptic marker, bassoon (red), and a postsynaptic marker, homer (blue). Box1 in B shows a zoomed-in view of ShhN immunolabeling in close proximity to bassoon and homer. Box1 and 2 in C are zoomed-in views of ShhC/FL immunolabeling also in close proximity to bassoon and homer. Scale bar: B,C: 10 µm. Additional examples are shown in [Fig. S4](Fig. S4)A,B. (D--H) Immunogold localization of ShhC/FL in the CA1 stratum radiatum of the mouse hippocampus, with 10 nm immunogold (arrows). Labeling is found both in the postsynaptic spine (D,E) and presynaptic terminal (pre; E--H). Note localizations on postsynaptic tubulovesicular structures in D and E, and associated with the postsynaptic (E), or presynaptic (G) membrane; in the latter case, it is just perisynaptic to the active zone. m, mitochondrion; asterisk, postsynaptic density. Scale bar: 200 nm. Additional examples are shown in [Fig. S4](Fig. S4)C--I.

In order to precisely reveal individual synapses, we next performed immunogold electron microscopy (immunoEM) of hippocampal neurons in brain tissues. Our previous immunoEM study of hippocampal neurons in mature brains showed that ShhN localized to both pre- and postsynaptic compartments ([@BIO040592C35]). Here, we focused on analyzing ShhC/FL. Similar to our previous findings of ShhN ([@BIO040592C35]), ShhC/FL immunogold labeling was seen in the presynaptic terminals and postsynaptic spines of hippocampal neurons in mature brains ([Fig. 4](#BIO040592F4){ref-type="fig"}D--H; [Fig. S4](Fig. S4)C--I). Therefore, in terms of synaptic distribution of Shh proteins, ShhN and ShhC/FL localize on both sides of the synapse.

Effects of fasting and exercise on Shh levels in mouse hippocampus {#s2e}
------------------------------------------------------------------

We went on to test whether fasting or exercise affected Shh mRNA level in mouse hippocampus. After subjecting mice to fasting or exercise ([@BIO040592C27]; also see Materials and Methods), we dissected the hippocampi and extracted mRNA or proteins for analysis. Using quantitative RT-PCR to analyze Shh mRNA, we found no significant changes in the hippocampi of mice subjected to fasting or exercise compared to control mice ([Fig. 5](#BIO040592F5){ref-type="fig"}A). When mice were subjected to fasting plus exercise, however, Shh mRNA level in the hippocampus was significantly reduced ([Fig. 5](#BIO040592F5){ref-type="fig"}A, top left). Consistently, RT-PCR analysis of the samples using a different PCR primer set produced the same results ([Fig. 5](#BIO040592F5){ref-type="fig"}A, top right). In contrast, mRNA level of Indian hedgehog (Ihh), another member of hedgehog family, was not different between mouse groups ([Fig. 5](#BIO040592F5){ref-type="fig"}A, bottom left). Likewise, Bdnf mRNA also was unchanged under any of the conditions ([Fig. 5](#BIO040592F5){ref-type="fig"}A, bottom left). Fig. 5.**Shh mRNA and ShhN protein levels in mouse hippocampus after fasting or exercising.** (A) Quantitative RT-PCR assay of Shh mRNA level in hippocampal tissues from mice subjected to fasting, exercise or fasting plus exercise. Top two graphs were the same hippocampal mRNA samples but amplified by using different PCR primers to Shh. The same hippocampal samples were also analyzed for Ihh (Indian hedgehog) and Bdnf mRNA. Each symbol represents an individual mouse. \**P*\<0.05, unpaired *t*-test. (B) Representative immunoblot showing similar levels of ShhN protein in the hippocampal tissues of mice between different conditions. C is quantification of B. Each symbol represents an individual mouse. ns, not statistically significant.

Finally, we examined Shh protein levels in the hippocampus of these mice. We decided to focus on examining ShhN protein because the ShhN antibody revealed ShhN protein specifically and performed reliably when analyzing mouse brain samples by immunoblotting ([Fig. 5](#BIO040592F5){ref-type="fig"}B). We found that, unlike Shh mRNA, ShhN protein level in the hippocampal samples was not appreciably altered in any of the mouse groups (eight mice for each group, [Fig. 5](#BIO040592F5){ref-type="fig"}C). The lack of a correlation between global Shh mRNA and protein can be caused by several factors such as protein turnover and other post-transcription mechanisms. Further experiments are required to address these questions.

DISCUSSION {#s3}
==========

We have provided evidence that postnatal neurons, including mature hippocampal neurons, produce an appreciable amount of Shh protein. When we systematically evaluated the abundance of Shh in brains of multiple ages from embryonic day 14 to postnatal day 30, we identified an embryonic age-dependent decline followed by a postnatal age-dependent resurgence. The postnatal, progressively-increased Shh expression coincides with brain development during which both neurons and glia are growing rapidly. The lack of change in Shh levels in cultured neurons after removing glia ([Fig. 2](#BIO040592F2){ref-type="fig"}C,D) suggests that neurons produce Shh. It will be important to determine that, at least in the hippocampus, if neurons are the sole Shh producers, and if all different subpopulations of neurons contribute to Shh production.

Among many questions that remain to be answered is whether hippocampal Shh signaling is autonomous or nonautonomous, or both. Hippocampal neurons possess the Shh pathway receptor, Patched and transducer, Smoothened, and preferentially traffic them to the dendrites or dendritic spines ([@BIO040592C34]), coincidentally the classical signal receiving sites for some neurotransmitters. In response to exogenously applied Shh, hippocampal neurons extend axons and grow more mature presynapses with a concomitant increase of Gli1 ([@BIO040592C28]; [@BIO040592C45]). It had been unclear, however, where in the hippocampus the endogenous Shh came from. Our current finding of Shh being produced by hippocampal neurons themselves points to a model in which Shh, either from neighboring or the same neurons, and alone or together, acts on recipient neurons and carries out functions accordingly. Another related and important future question is whether in neurons all Shh protein forms are present and functional. The abundance of ShhN in neurons suggests that this form is likely a functionally active form, as it is known for other types of cells ([@BIO040592C4]; [@BIO040592C25]). Given the implications that ShhFL has functions in some cells ([@BIO040592C40]), and ShhC may be the extracellularly-released form ([@BIO040592C25]; [@BIO040592C2]), it will be interesting and necessary to pinpoint in the future the exact Shh biogenesis process in hippocampal neurons, and determine if the distinct Shh forms have specialized functions.

MATERIALS AND METHODS {#s4}
=====================

Animals {#s4a}
-------

All animal procedures were approved by the NIA Animal Care and Use Committee and complied with the NIH Guide for Care and Use of Laboratory Animals. Timed pregnant female Sprague-Dawley rats were used as the source of embryonic brain tissues. Postnatal rats (postnatal day 1 to p30) of either sex were used as the source of cortical, cerebellar and hippocampal tissues. Hippocampi of 8-week-old male C57BL/6 mice from a previous study ([@BIO040592C39]) were used for immunogold labeling. Hippocampi of 6-month-old male C57BL/6 mice also from a previous study ([@BIO040592C27]) were used for fasting and exercise experiments.

Reagents {#s4b}
--------

Anti-ShhN (\#2207; epitope surrounding Glu53 of human Shh) and cFos (\#2250S) were from Cell Signaling Technology. Anti-ShhN (5E1) was from the Developmental Studies Hybridoma Bank. Anti-ShhC (\#S9947; epitope-amino acids 199-437 of mouse Shh), anti-synaptophysin (\#S5768), anti-map2 (\#M9942) and anti-actin (\#A5441 and \#A2066) were from Sigma-Aldrich. smi312 antibody (\#SMI-312R) was from Convance/BioLegend. Anti-bassoon (\#141002), anti-homer1 (\#160004), anti-Aldh1L1 (\#278003), and anti-Gfap (\#173002) were from Synaptic Systems. Anti-psd95 (\#7E3-1B8) was from Thermo Fisher Scientific. Bicuculline (\#0130) and PACAP (\#1183) were from Tocris Bioscience. Purmorphamine (\#ALX-420-045) was from Enzo Biochem Inc. Cytosine β-D-arabinofuranoside (\#C1768) and Tetrodotoxin (\#T5551) were from Sigma-Aldrich.

Hippocampal neuron culture {#s4c}
--------------------------

Cultures of hippocampal neurons were prepared from embryonic day 18 rat hippocampi as described ([@BIO040592C22]; [@BIO040592C45]). Dissociated neurons were seeded at low density (∼50 cells mm^−2^) for immunofluorescence, and high density (150--200 cells mm^−2^) for immunoblot and RT-PCR analysis. The neurons were grown in neurobasal medium supplemented with B27 (Invitrogen). For immunofluorescence, the neurons were grown on polylysine (1 mg ml^−1^)-coated glass coverslips (no 1.5). For immunoblotting and RT-PCR, the neurons were grown in polylysine-coated plastic dishes (0.1 mg ml^−1^). Neuron-enriched cultures were prepared following a protocol ([@BIO040592C41]) with minor modifications. Briefly, one day after initial cell seeding, 2.5 µM of cytosine β-D-arabinofuranoside (AraC) was added. Forty-eight hours later, araC-containing medium was replaced by the growth medium composed of 50% fresh neurobasal medium with B27, 25% of conditioned medium from cortical neurons, and 25% of conditioned medium from glial cells.

DNA constructs and transfection {#s4d}
-------------------------------

The full-length and N-terminal fragment of mouse Shh constructs were kindly provided by Dr James K. Chen (Stanford University). Human embryonic kidney (HEK) 293 cells obtained from ATCC were cultured according to the manufacturer\'s instructions and transfected using a calcium phosphate-based kit (CalPhos mammalian transfection kit; \#631312, Clontech).

Quantitative PCR (RT-qPCR) {#s4e}
--------------------------

Total RNA was extracted from brain extracts or cell pellets of cultured neurons with RNeasy Mini Kit (Qiagen). RNA concentration was measured with NanoDrop 2000. Five hundred nanograms of total RNA was reverse transcribed using SuperScript III First-Strand Synthesis System (Invitrogen). qPCR was carried out using SYBR Green master mix on 3 µl of cDNA, and analyzed with ViiA 7 (Applied Biosystems). Primer sequences used were as follows: *Shh (d)*: 5′-TCAGAGGTGCAAAGACAAGTTA-3′ and 5′-ACCCTCATAGTGTAGAGACTCC-3′; *Shh (e)*: 5′-GCCGATATGAAGGGAAGATCAC-3′ and 5′-GGAGATGGCCAAGGCATTTA-3′; *Gli1*: 5′-TCGACCTGCAAACCGTAATC-3′ and 5′-CATCTGAGGTGGGAATCCTAAAG-3′; *bassoon*: 5′-CAGCTACGAGCACGGTAAAG −3′ and 5′-TGGGAGTCAGAGGGATATGTAG-3′. The following primers were from QuantiTech primer assays (Qiagen): *Shh (f)*, \# QT00184912; *Bdnf*: \# QT00375998; *synaptophysin*: \# QT02338056. Primer sequences for *Ihh* were described in [@BIO040592C26]. ΔΔCt analysis was used to normalize target gene expression to RPLO reference gene expression. Target gene expression of embryonic and postnatal brain tissues was then normalized to expression at postnatal day 1 (p1).

Immunoblot analysis {#s4f}
-------------------

Tissues or cell pellets were sonicated in RIPA buffer (\#89900, Thermo Fisher Scientific) containing protease and phosphatase inhibitors (\#78444, Thermo Fisher Scientific). Following centrifugation at 10,000 ***g*** for 10 min at 4°C, the supernatant was collected and the amount of total proteins was estimated with a Pierce BCA protein assay kit (Pierce Biotechnology). Protein samples were separated by 4--20% Bis-Tris SDS-PAGE and transferred to nitrocellulose membranes. Following incubation with blocking buffer (5% dry milk and 0.05% Tween20 in PBS), the membranes were incubated overnight at 4°C in the blocking buffer containing one of the following antibodies: Shh 5E1 at 1:250; ShhC and Aldh1L1 at 1:500; ShhN, psd95, Gfap, Aldh1L1, and cFos at 1:1000; synaptophysin and actin at 1:5000. The membranes were then washed (0.1% Tween20 in PBS) and incubated with appropriate peroxidase-conjugated secondary antibodies. The proteins were visualized using a chemiluminescence kit from Pierce or Kindle Biosciences. The intensity of protein bands was analyzed using ImageJ software.

Synaptosomal preparations were purchased from Synaptic Systems. Twenty micrograms of protein from each sample were used in immunoblots. For immunoblots of extracellular ShhN, the culture media were concentrated 25-fold and then tenfold using Amicon centrifugal filters (10 kD). Thirty micrograms of protein from each sample were analyzed by immunoblots.

Immunocytochemistry, fluorescence microscopy and image analysis {#s4g}
---------------------------------------------------------------

Immunofluorescence labeling was performed as previously described ([@BIO040592C45]). Briefly, neurons were fixed in 4% paraformaldehyde and 4% sucrose for 15 min. Following permeabilization in 0.2% Triton X-100 and blocking in 10% BSA, the neurons were incubated with antibody to ShhN (1:250), ShhC (1:250), smi-312 (1:1000), map2 (1:2000), bassoon (1:250), or homer (1:250). After washing, the neurons were incubated with appropriate fluorescence-tagged secondary antibodies. The glass coverslips containing the labeled neurons were mounted in Prolong Gold antifade reagent (Thermo Fisher Scientific).

Confocal images were acquired with an Apochromat 63×/1.4 numerical aperture objective lens on a Zeiss LSM 880 microscope with Airyscan (Carl Zeiss). For each antibody labeling, the image acquisition settings were kept the same between different experiments. The brightness and contrast levels of the images were adjusted in Adobe Photoshop, and compiled in Adobe Illustrator. No additional digital image processing was performed. Control cells omitting the primary antibody showed no fluorescence labeling.

We used ImageJ (NIH) software to compare the immunofluorescence intensity for ShhN or ShhC in soma and neurites. We also estimated the relative proportion of immunolabeled puncta for ShhN, ShhC or co-localized ShhN and ShhC (touching or overlapping green and red pixels). Randomly selected neurons from three different cultures were used for the analysis. For each neuron, 100 immunolabeled puncta were counted. Counting was performed by an observer (E.C.) who was familiar with the analyzing criteria, but who was unaware of the experimental details until after analyses were complete.

Immunoelectron microscopy {#s4h}
-------------------------

Post-embedding immunogold labeling was performed as described previously ([@BIO040592C33]; [@BIO040592C45]). Following perfusion with 4% PFA plus 0.5% glutaraldehyde, mouse brain tissue was cryoprotected and frozen in a Leica CPC and then processed for freeze-substitution in Lowicryl HM-20 resin in a Leica AFS. Thin sections were incubated in 10% normal goat serum, then overnight in primary antibody, and followed by incubation for 1 h with 10 nm immunogold. Sections were stained with uranyl acetate and lead citrate. Control immunogold labeling of sections omitting the primary antibody showed only rare gold particles.

Presentation of data and statistics {#s4i}
-----------------------------------

All graphs were produced using KaleidaGraph (Synergy) software. Statistical comparisons were calculated using the unpaired Student\'s *t*-test. All results are expressed as mean±s.e.m.
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